Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study

BACKGROUND: Older individuals often have a reduced immune response to influenza vaccination, which might be improved by administering a higher vaccine dose. We compared the immune response to two single doses of the AS03(A)-adjuvanted H5N1 pandemic vaccine (3.75 μg hemagglutinin of A/Vietnam/1194/20...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillard, Paul, Giet, Didier, Heijmans, Stéphane, Dramé, Mamadou, Walravens, Karl, Roman, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233031/
https://www.ncbi.nlm.nih.gov/pubmed/25354581
http://dx.doi.org/10.1186/1745-6215-15-419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233031/
https://www.ncbi.nlm.nih.gov/pubmed/25354581
http://dx.doi.org/10.1186/1745-6215-15-419

Ejemplares similares